Publications & Works

Publication Network
Journal articles indexed in SCI, SSCI, and AHCI

Global Co-regulatory Cross Talk Between m6A and m5C RNA Methylation Systems Coordinate Cellular Responses and Brain Disease Pathways

Orji O. C., Stones J., Rajani S., Markus R., öz M., Knight H. M.
Molecular Neurobiology , vol.62, no.4, pp.5006-5021, 2025 (SCI-Expanded) identifier identifier

The effects of<i> UGT1A4</i> and<i> ABCB1</i> polymorphisms on clozapine and Ndesmethyl clozapine plasma levels in Turkish schizophrenia patients

Ozdemir F., Oz M. D., Tok K. C., Dural E., Kır Y., Gumustas M., et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY , vol.495, 2025 (SCI-Expanded) identifier identifier identifier

The role of tissue persistent organic pollutants and genetic polymorphisms in patients with benign and malignant kidney tumors

KOCAGÖZ R., Onat l., Oz M., Turna B., Kumbaraci B. S., ORMAN M. N., et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.110, 2024 (SCI-Expanded) identifier identifier identifier

Blood and tissue levels of persistent organic pollutants and genetic susceptibility in patients with breast cancer

Onat İ., Kocagöz R., DEMİRBÜGEN ÖZ M., Yeniay L., Tiftikçioğlu Y. Ö., Zekioğlu O., et al.
Environmental Toxicology and Pharmacology , vol.108, 2024 (SCI-Expanded) identifier identifier

Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders

Knight H. M., Öz M., PerezGrovas-Saltijeral A.
Neural Regeneration Research , vol.19, no.6, pp.1256-1261, 2024 (SCI-Expanded) identifier identifier

Assessment of Genetic and Lifestyle Factors on Clozapine and N-desmethylclozapine Plasma Levels in Schizophrenia Patients

Demirbügen Öz M., Özdemir F., Tok K. C., Dural E., Kır Y., Ulusoy M., et al.
PHARMACOPSYCHIATRY CLINICAL PHARMACOLOGY, PSYCHIATRY, PSYCHOLOGY, NEUROPHYSIOLOGY, NEUROBIOLOGY, GERONTOPSYCHIATRY , vol.57, no.2, pp.87, 2024 (SCI-Expanded) Sustainable Development

The Potential Role of <i>POR*28</i> and <i>CYP1A2*F</i> Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients

Demirbügen Öz M., Ozdemir F., Tok K. C., Dural E., Kir Y., Ulusoy M., et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY , vol.19, no.5, pp.319-327, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

Association between superoxide dismutase 2, glutathione peroxidase 1, xeroderma pigmentosum group d gene variations, and head and neck squamous cell cancer susceptibility

Kose G., Oz M., CÖMERT E., SÜZEN H. S.
ARCHIVES OF BIOLOGICAL SCIENCES , vol.74, no.2, pp.181-189, 2022 (SCI-Expanded) Creative Commons License identifier identifier

The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants

DEMİRBÜGEN ÖZ M., Ozdemir F., SÜZEN H. S.
Current drug metabolism , vol.22, no.8, pp.596-627, 2021 (SCI-Expanded) identifier identifier identifier

The role of COMT polymorphism in modulation of prefrontal activity during verbal fluency in bipolar disorder

Devrimci-Ozguven H., Alici Y. H., DEMİRBÜGEN ÖZ M., SÜZEN H. S., Kale H. E., Baskak B.
NEUROSCIENCE LETTERS , vol.738, 2020 (SCI-Expanded) identifier identifier identifier

Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients

DEMİRBÜGEN ÖZ M., BASKAK B., UÇKUN Z., Artun N. Y., Ozdemir H., Ozel T. K., et al.
PHARMACOGENOMICS JOURNAL , vol.20, no.3, pp.443-450, 2020 (SCI-Expanded) identifier identifier identifier

A Novel PCR-RFLP Method for Detection of POR*28 Polymorphism and its Genotype/Allele Frequencies in a Turkish Population

Ozdemir F., DEMİRBÜGEN ÖZ M., SÜZEN H. S.
CURRENT DRUG METABOLISM , vol.20, no.10, pp.845-851, 2019 (SCI-Expanded) identifier identifier identifier

The relationship between the serotonin 2A receptor gene-1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients

DEMİRBÜGEN ÖZ M., UÇKUN Z., Yuce-Artun N., BASKAK B., Ozdemir H., Ozel T. K., et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , vol.33, no.5, 2018 (SCI-Expanded) identifier identifier identifier

The effect of additional noradrenergic and serotonergic depletion on a lateralised choice reaction time task in rats with nigral 6-OHDA lesions

Lindgren H. S., Demirbugen M., Bergqvist F., Lane E. L., Dunnett S. B.
Experimental Neurology , vol.253, pp.52-62, 2014 (SCI-Expanded) Creative Commons License identifier identifier identifier
Articles Published in Other Journals

THE COMPARISON OF ANTIOXIDANT AND ANTIBACTERIAL ACTIVITY OF NOVEL PYRIMIDO[1,2-a]PYRIMIDINE COMPOUNDS

BAYRAMOĞLU D., DEMIRBÜGEN OZ M., KIYMACI M. E.
Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.47, no.1, pp.1-8, 2023 (Scopus) Creative Commons License identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences

Assessment of Genetic and Lifestyle Factors on Clozapine and N-desmethylclozapine Plasma Levels in Schizophrenia Patients

Demirbügen Öz M., Özdemir F., Tok K. C., Dural E., Kır Y., Ulusoy M., et al.
XVth Symposium of the Task Force Therapeutic Drug Monitoring of the AGNP, Freiburg, Germany, 20 - 22 March 2024, pp.87, (Summary Text) Sustainable Development

IN SILICO MOLECULAR PATHWAY IDENTIFICATION OF CROHN’S DİSEASE REGARDING THE POTENTIAL EFFECT OF ENDOCRINE DISRUPTING BISPHENOL A

DEMİRBÜGEN ÖZ M.
EURO ASIA 11. INTERNATIONAL CONGRESS ON APPLIED SCIENCES, Turkey, 27 May 2023, (Summary Text)

EVALUATION OF THE POTENTIAL INFLUENCE OF CADMIUM ON MOLECULAR MECHANISMS IN THE OCCURRENCE OF PROSTATE CANCER THROUGH DATA-MINING

DEMİRBÜGEN ÖZ M.
EURO ASIA 11. INTERNATIONAL CONGRESS ON APPLIED SCIENCES, Turkey, 27 May 2023, (Summary Text)

THE IMPACT OF THE CYTOCHROME P450 3A4 (CYP3A4*22) POLYMORPHISM ON TACROLIMUS DOSE REQUIREMENTS AND EXPOSURE DURING EARLY PERIOD FOLLOWING KIDNEY TRANSPLANTATION

DEMİRBÜGEN ÖZ M., KEVEN K., SÜZEN H. S.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

IDENTIFYING POTENTIAL GENETIC BIOMARKERS OF THE CARDIOTOXICITY INDUCED BY ANTHRACYLINES

DEMİRBÜGEN ÖZ M.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

USEFUL PHARMACOGENETIC BIOMARKERS IN CHILDHOOD CANCER TREATMENT AND ADVERSE DRUG REACTIONS

DEMİRBÜGEN ÖZ M.
7. INTERNATIONAL GEVHER NESİBE HEALTH SCIENCES CONFERENCE, Kayseri, Turkey, 16 - 17 April 2021, (Summary Text)

THE IMPORTANCE OF THE CYTOCHROME P450 3A5 (CYP3A5*3) POLYMORPHISM ON TACROLIMUS DOSE REQUIREMENTS AND TROUGH LEVELS DURING EARLY PERIOD AFTER KIDNEY TRANSPLANTATION

DEMİRBÜGEN ÖZ M., KEVEN K., SÜZEN H. S.
2nd INTERNATIONAL CONGRESS OF MULTIDISCIPLINARY STUDIES IN MEDICAL SCIENCES, Ankara, Turkey, 13 - 14 February 2021, (Summary Text)

The role of genetic and epigenetic factors in major depressive disorder

DEMİRBÜGEN ÖZ M., SÜZEN H. S.
5th International Congress onEpigenetics Chromatin, Viyana, Austria, 22 - 23 August 2019, (Summary Text)

The Role of Comt Polymorphisms in Modulation of Prefrontal Activity During Verbal Fluency in Bipolar Disorder

HOŞGÖREN Y., DEVRİMCİ ÖZGÜVEN H., BASKAK B., DEMİRBÜGEN ÖZ M., SÜZEN H. S., DUMAN B.
Bipolar Bozukluklar Derneği Bipolar Bozukluk Araştırmacı Klinisyen Eğitim Toplantısı (BAKET), Turkey, 15 - 16 September 2018, (Summary Text)

THE POSSSIBLE ASSOCIATION BETWEEN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) GENETIC POLYMORPHISM VAL66MET AND SUSCEPTIBILITY TO BIPOLAR DISORDERS (BPD)

DEMİRBÜGEN ÖZ M., HOŞGÖREN Y., DUMAN B., BASKAK B., DEVRİMCİ ÖZGÜVEN H., SÜZEN H. S.
12th International Symposium on Pharmaceutical Sciences (ISOPS-12), 26 - 29 June 2018, (Summary Text)

THE 5-HYDROXYTRIPTAMINE 2A RECEPTOR -1438A/G AND 102T/C POLIMORPHISMS AND NAUSEA SIDE EFFECT IN CITALOPRAM TREATED MAJOR DEPRESSIVE DISORDER PATIENTS

DEMİRBÜGEN ÖZ M., UÇKUN Z., YÜCE ARTUN N., DEVRİMCİ ÖZGÜVEN H., SÜZEN H. S.
12th International Symposium on Pharmaceutical Sciences, 26 - 29 June 2018, (Summary Text)

THE RELATIONSHIP BETWEEN THE DIFFERENT GENETIC POLYMORPHISMS AND METHYLPHENIDATE INDUCED ADVERSE DRUG REACTIONS IN ATTENTION DEFICIT HYPERACTIVITY DISORDER PATIENTS

DEMİRBÜGEN M., SÜZEN H. S.
1st International Food and Medicine Congress, 24 - 27 May 2018, (Summary Text)

COMMON GENE POLYMORPHISMS IN ANTIOXIDANT ENZYME SYSTEMS AND ITS RELATION WITH THE NUTRION

DEMİRBÜGEN M., SÜZEN H. S.
1st International Food and Medicine Congress, 24 - 27 May 2018, (Summary Text)

Kidney, breast and stomach cancers in relation to internal concentrations of persistent organic pollutants, DNA damage markers and related polymorphisms

ORHAN H., SÜZEN H. S., KOCAGÖZ R., ONAT İ., DEMİRBÜGEN ÖZ M., TURNA B., et al.
The 10th Congress of the Toxicology in Developing Countries (CTDC10th), 17 - 22 April 2018, vol.4, pp.18, (Full Text) Sustainable Development

Aspirin Kullanımı Ve Kolesterol Değerleri Arasındaki İlişki

Demirel B., DEMİRBÜGEN M.
9th Asian Conference on Emergency Medicine and 13th Turkish Emergency Medicine Congress, 22 - 25 November 2017, (Full Text)

The Serotonin 2A Receptor Gene -1438A/G Polymorphism and Sertraline Induced Nausea in Major Depressed Turkish Patients

DEMİRBÜGEN M., UÇKUN Z., SÜZEN H. S.
2nd International Gazi Pharma Symposium Series(GPSS-2017), Ankara, Turkey, 11 - 13 October 2017, (Summary Text)

Sitalopram kullanan major depresyon hastalarında bulantı/kusma advers etkisinin serotonin-2A reseptör geni -1438A/G polimorfizmi ile ilişkisinin incelenmesi

DEMİRBÜGEN M., SÜZEN H. S.
1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu, Turkey, 1 - 02 June 2017, (Summary Text)

Antipsychotic Drugs and the Risk of Sudden Cardiac Death

DEMİRBÜGEN M., SÜZEN H. S.
The 2nd International Congress and Workshop of Forensic Toxicology, 26 - 30 May 2016

5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment

DEMİRBÜGEN M., UÇKUN Z., YÜCE N., BASKAK B., SÜZEN H. S.
Turk Heltox Toxicology Congress, 21 - 24 October 2015

THE ASSOCIATION OF SEROTONINE 2A RECEPTOR 102 T/C POLYMORPHISM AND NAUSEA IN CITALOPRAM TREATED PATIENTS

DEMİRBÜGEN M., BASKAK B., Devrimci Özgüven H., Kızıl Özel T., SÜZEN H. S.
11th İnternational Symposium on Pharmaceutical Sciences, 9 - 12 June 2015, (Summary Text)

The association of serotonin 2A receptor 102T C polymorphism and nausea in citalopram treated patients

DEMİRBÜGEN M., BASKAK B., ÖZEL KIZIL E. T., ÖZGÜVEN H., SÜZEN H. S.
11th Internetional Symposium on Pharmaceutical Sciences, 9 - 12 June 2015

Toxicology, Pharmacology, Detection and Legal Status of Synthetic Cannabinoids

YILMAZ S., DEMİRBÜGEN M., YALÇIN C. Ö.
1st International Congress and Workshop of Forensic Toxicology, 29 - 30 November 2014, (Summary Text)

The effect of additional noradrenergic and serotonergic depletion on lateralised choice reaction time task in rats with nigral 6-OHDA lesions

DEMİRBÜGEN ÖZ M., Lindgren H. S., Lane E. L.
50th Congress of the European-Societies-of-Toxicology, Edinburgh, Saint Helena, 7 - 10 September 2014, vol.229, (Summary Text) Creative Commons License identifier

6-OHDA İLE UNİLATERAL LEZYON OLUŞTURULAN SIÇANLARDA SEROTONİN, NORADRENALİN VE DOPAMİNİN MOTOR ÖĞRENME KABİLİYETİ ÜZERİNE ETKİSİ

DEMİRBÜGEN M., Lindgren H., Lane E.
III. Türk Toksikoloji Derneği Sempozyumu, Turkey, 12 - 14 June 2014, (Summary Text)
Books

Çevresel kimyasallara maruziyet ve epigenetik

DEMİRBÜGEN ÖZ M.
in: CUMHURİYETİN 100. YILINDA ECZACILIKTA YENİLİKLER 4, Asuman Bozkır, İlkay Yıldız, Editor, Ankara Üniversitesi Yayınları, pp.537-550, 2023

Major Depresyonda Bireyselleştirilmiş Tedavi ve Farmakogenetiğin Önemi

DEMİRBÜGEN ÖZ M., SÜZEN H. S.
in: Eczacılıkta Yenilikler 3, Özçelikay Gülbin, Yıldız İlkay, Editor, Ankara Üniversitesi Yayınları, Ankara, pp.447-456, 2020

Radyasyon ve radyoaktif materyallerin toksik etkileri

DEMİRBÜGEN M., ÜSTÜNDAĞ A., ÜLKER Ö., UÇKUN Z., YILMAZ SARIALTIN S.
in: Casarett and Doull's Toksikolojinin Temelleri, Sinan Süzen, Ahmet Oğuz Ada, Bulut Demirel, Onur Erdem, Gonca Çakmak Demircigil, Pınar Erkekoğlu, Editor, Nobel Tıp Kitabevi, Ankara, pp.373-380, 2017
Metrics

Publication

42

Citation (WoS)

29

H-Index (WoS)

3

Citation (Scopus)

39

H-Index (Scopus)

3

Project

1

Open Access

4
UN Sustainable Development Goals